US-based Sanuwave Health has obtained a patent from the US Patent and Trademark Office (USPTO) for its new extracorporeal applicator.
Sanuwave Health’s new extracorporeal applicator helps in the elimination of cardiovascular occlusions and atherosclerosis, regardless of vessel dimension.
The patent entitled ‘Extracorporeal Shock Wave Device’ protects a special reflector geometry that will be applied in the company’s future applicators.
The applicator design has its reflector opening intersecting the focal line of an ellipse at a non-perpendicular angle, while on the contrary the existing applicators use classic reflectors that intersect the focal line of an ellipse only at a perpendicular angle.
Sanuwave Health CEO Joseph Chiarelli noted this new patent adds to the company’s intellectual property portfolio.
"This new type of applicator can be used for cardiology, endovascular, as well as other applications. Our strategy is to maximize the value of SANUWAVE’s shock wave technology – to expand the technology’s use into as many applications as possible via this new applicator design," Chiarelli added.
The new patent has a term extending to April 2031.
Currently, the company has 36 patents (issued or pending) on focused shock waves in medical and non-medical applications.
Sanuwave Health applies its patented PACE technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.